<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article
  PUBLIC "-//NLM//DTD Journal Publishing DTD v2.3 20070202//EN" "journalpublishing.dtd">
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" article-type="research-article">
<front>
<journal-meta>
<journal-id journal-id-type="publisher-id">ANG</journal-id>
<journal-id journal-id-type="hwp">spang</journal-id>
<journal-id journal-id-type="nlm-ta">Angiology</journal-id>
<journal-title>Angiology</journal-title>
<issn pub-type="ppub">0003-3197</issn>
<issn pub-type="epub">1940-1574</issn>
<publisher>
<publisher-name>SAGE Publications</publisher-name>
<publisher-loc>Sage CA: Los Angeles, CA</publisher-loc>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="doi">10.1177/0003319712453305</article-id>
<article-id pub-id-type="publisher-id">10.1177_0003319712453305</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Coronary Heart Diseases</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>Neutrophil to Lymphocyte Ratio Is Associated With the Severity of Coronary Artery Disease in Patients With ST-Segment Elevation Myocardial Infarction</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author" corresp="yes">
<name>
<surname>Şahin</surname>
<given-names>Durmuş Yıldıray</given-names>
</name>
<degrees>MD</degrees>
<xref ref-type="aff" rid="aff1-0003319712453305">1</xref>
<xref ref-type="corresp" rid="corresp1-0003319712453305"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Elbasan</surname>
<given-names>Zafer</given-names>
</name>
<degrees>MD</degrees>
<xref ref-type="aff" rid="aff1-0003319712453305">1</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Gür</surname>
<given-names>Mustafa</given-names>
</name>
<degrees>MD</degrees>
<xref ref-type="aff" rid="aff1-0003319712453305">1</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Yıldız</surname>
<given-names>Ali</given-names>
</name>
<degrees>MD</degrees>
<xref ref-type="aff" rid="aff2-0003319712453305">2</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Akpınar</surname>
<given-names>Onur</given-names>
</name>
<degrees>MD</degrees>
<xref ref-type="aff" rid="aff3-0003319712453305">3</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Icen</surname>
<given-names>Yahya Kemal</given-names>
</name>
<degrees>MD</degrees>
<xref ref-type="aff" rid="aff1-0003319712453305">1</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Turkoglu</surname>
<given-names>Caner</given-names>
</name>
<degrees>MD</degrees>
<xref ref-type="aff" rid="aff1-0003319712453305">1</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Tekin</surname>
<given-names>Kamuran</given-names>
</name>
<degrees>MD</degrees>
<xref ref-type="aff" rid="aff1-0003319712453305">1</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Kuloglu</surname>
<given-names>Osman</given-names>
</name>
<degrees>MD</degrees>
<xref ref-type="aff" rid="aff1-0003319712453305">1</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Çaylı</surname>
<given-names>Murat</given-names>
</name>
<degrees>MD</degrees>
<xref ref-type="aff" rid="aff1-0003319712453305">1</xref>
</contrib>
</contrib-group>
<aff id="aff1-0003319712453305">
<label>1</label>Department of Cardiology, Adana Numune Education and Research Hospital, Adana, Turkey</aff>
<aff id="aff2-0003319712453305">
<label>2</label>Department of Cardiology, School of Medicine, Harran University, Şanlıurfa, Turkey</aff>
<aff id="aff3-0003319712453305">
<label>3</label>Department of Cardiology, Private Metropark Hospital, Adana, Turkey</aff>
<author-notes>
<corresp id="corresp1-0003319712453305">Durmuş Yıldıray Şahin, Department of Cardiology, Adana Numune Education and Research Hospital, Adana 01170, Turkey. Email: <email>dysahin79@hotmail.com</email></corresp>
</author-notes>
<pub-date pub-type="epub-ppub">
<month>8</month>
<year>2013</year>
</pub-date>
<volume>64</volume>
<issue>6</issue>
<fpage>423</fpage>
<lpage>429</lpage>
<permissions>
<copyright-statement>© The Author(s) 2012</copyright-statement>
<copyright-year>2012</copyright-year>
<copyright-holder content-type="sage">SAGE Publications</copyright-holder>
</permissions>
<abstract>
<p>We assessed the relationship between the severity of coronary artery disease assessed by SYNTAX score (SS) and neutrophil to lymphocyte ratio (N:L ratio) in patients with ST elevation myocardial infarction (STEMI). In total, 840 patients with STEMI in whom primary percutaneous coronary intervention was performed were prospectively included (622 male, 218 female; mean age 58.6 ± 12.4 years). Total and differential leukocyte counts and other biochemical markers were measured at admission. Patients were categorized into tertiles on the basis of SS. The N:L ratio of SS<sub>high</sub> group was higher compared with SS<sub>low</sub> and SS<sub>mid</sub> groups (<italic>P</italic> &lt; .001 for all). Multivariate regression analysis showed that N:L ratio (β = .277, <italic>P</italic> &lt; .001), ejection fraction (β = −.086, <italic>P</italic> = .012), age (β = .104, <italic>P</italic> = .004), and diabetes (β = .152, <italic>P</italic> &lt; .001) were the independent predictors for SS in patients with STEMI.</p>
</abstract>
<kwd-group>
<kwd>neutrophil</kwd>
<kwd>lymphocyte</kwd>
<kwd>myocardial infarction</kwd>
</kwd-group>
</article-meta>
</front>
<body>
<sec id="section1-0003319712453305">
<title>Introduction</title>
<p>Inflammation plays a pivotal role in the progression of atherosclerosis.<sup>
<xref ref-type="bibr" rid="bibr1-0003319712453305">1</xref>,<xref ref-type="bibr" rid="bibr2-0003319712453305">2</xref>
</sup> White blood cell (WBC) count and the neutrophil and lymphocyte have been investigated as inflammatory markers to predict cardiovascular outcomes in patients with coronary artery disease (CAD).<sup>
<xref ref-type="bibr" rid="bibr3-0003319712453305">3</xref>
<xref ref-type="bibr" rid="bibr4-0003319712453305"/>
<xref ref-type="bibr" rid="bibr5-0003319712453305"/>
<xref ref-type="bibr" rid="bibr6-0003319712453305"/>–<xref ref-type="bibr" rid="bibr7-0003319712453305">7</xref>
</sup> High neutrophil to lymphocyte ratio (N:L ratio) was reported to be associated with increased cardiac mortality in clinically stable patients with CAD.<sup>
<xref ref-type="bibr" rid="bibr6-0003319712453305">6</xref>,<xref ref-type="bibr" rid="bibr7-0003319712453305">7</xref>
</sup> Increased N:L ratio was also reported to be associated with the presence and long-term mortality of ST elevation myocardial infarction (STEMI).<sup>
<xref ref-type="bibr" rid="bibr8-0003319712453305">8</xref>
</sup>
</p>
<p>The SYNTAX score (SS) is an angiographic lesion-based scoring system originally invented to evaluate the complexity of CAD.<sup>
<xref ref-type="bibr" rid="bibr9-0003319712453305">9</xref>
</sup> It is able to aid revascularization decisions and predicts mortality and morbidity in patients with CAD.<sup>
<xref ref-type="bibr" rid="bibr9-0003319712453305">9</xref>
<xref ref-type="bibr" rid="bibr10-0003319712453305"/>
<xref ref-type="bibr" rid="bibr11-0003319712453305"/>
<xref ref-type="bibr" rid="bibr12-0003319712453305"/>
<xref ref-type="bibr" rid="bibr13-0003319712453305"/>–<xref ref-type="bibr" rid="bibr14-0003319712453305">14</xref>
</sup>
</p>
<p>Although predictive value of N:L ratio in patients with stable CAD and STEMI is well known, the relationship between N:L ratio and the severity of CAD in patients with STEMI has not been clearly determined.</p>
<p>In this study, we aimed to assess relationship between the severity of coronary atherosclerosis assessed by SS and N:L ratio in patients with STEMI.</p>
</sec>
<sec id="section2-0003319712453305" sec-type="methods">
<title>Methods</title>
<sec id="section3-0003319712453305">
<title>Study Population</title>
<p>In this study, 840 patients with STEMI in whom primary percutaneous coronary intervention (PCI) was performed in our cardiology clinic between January 2011 and March 2012 were included (622 male, 218 female; mean age 58.6 ± 12.4 years). To achieve homogeneous distribution, patients were categorized into tertiles on the basis of SS. Those with a history of acute myocardial infarction (AMI), PCI, coronary artery bypass graft, infectious or inflammatory disease, severe liver or renal disease, neoplasm, or hematological disorders were excluded from our study. The STEMI was defined based on the criteria formulated by the American College of Cardiology and the European Society of Cardiology<sup>
<xref ref-type="bibr" rid="bibr15-0003319712453305">15</xref>
</sup>: an increase in troponin I &gt;1 ng/mL with a new ST elevation was measured from the J point in ≥2 contiguous leads with at least 0.2 mV in leads V1, V2, and V3, or at least 0.1 mV in the remaining leads during the first 12 hours after the onset of symptoms.</p>
<p>Baseline characteristics of patients with STEMI were recorded, such as age, gender, body mass index, history of hyperlipidemia, smoker at admission, history of hypertension (HT), history of diabetes mellitus (DM), family history, medications, systolic blood pressure (SBP), diastolic blood pressure (DBP) and heart rate (beats/min). Ejection fraction (EF) was determined using Simpson method, according to the suggestions of the American Society of Echocardiography.<sup>
<xref ref-type="bibr" rid="bibr16-0003319712453305">16</xref>
</sup> The study was performed according to the recommendations of Declaration of Helsinki on Biomedical Research Involving Human Subjects. The institutional ethics committee approved the study protocol, and each participant provided written informed consent.</p>
</sec>
<sec id="section4-0003319712453305">
<title>Blood Samples</title>
<p>Samples of peripheral venous blood were drawn from antecubital vein at admission. Blood counts were measured by a Sysmex K-1000 (Block Scientific, Bohemia, New York) autoanalyzer within 5 minutes of sampling. Plasma triglyceride, low-density lipoprotein (LDL), high-density lipoprotein (HDL), glucose, uric acid (UA), and creatinine concentrations were measured with an automated chemistry analyzer (Abbott Aeroset, Minnesota, USA) using commercial kits (Abbott). Activity of creatine kinase MB (CK-MB) was measured with an assay that uses 2 monoclonal antibodies (CKMB STAT) on an Elecsys 2010 analyzer (Roche Diagnostics, Basel, Switzerland) by electrochemiluminescence immunoassay.</p>
</sec>
<sec id="section5-0003319712453305">
<title>SYNTAX Score and Angiographic Analysis</title>
<p>All patients underwent selective coronary angiography using the Judkins technique. Coronary lesions leading to ≥50% diameter stenosis in vessels ≥1.5 mm was scored separately and added together to provide the cumulative SS which was prospectively calculated using the SS algorithm on the baseline diagnostic angiogram.<sup>
<xref ref-type="bibr" rid="bibr9-0003319712453305">9</xref>,<xref ref-type="bibr" rid="bibr17-0003319712453305">17</xref>
</sup> Two experienced interventional cardiologists analyzed the SS; the opinion of a third analyst was obtained and the final judgment was made by consensus in cases of disagreement. The final score was calculated from the individual lesion scores by analysts who were blinded to procedural data and clinical outcome.</p>
</sec>
<sec id="section6-0003319712453305">
<title>Statistical Analysis</title>
<p>All analyses were conducted using SPSS 17.0 for Windows statistical software (SPSS, Inc., Chicago, Illinois, USA). Continuous variables were expressed as mean ± standard deviation and categorical variables were expressed as percentages. Distribution of parametric values was evaluated with 1-sample Kolmogorov-Smirnov test. Comparison of categorical variables between the groups was performed using the chi-square (χ<sup>
<xref ref-type="bibr" rid="bibr2-0003319712453305">2</xref>
</sup>) test. Analysis of variance was used in the analysis of continuous variables. A stratified post hoc analysis of clinical and laboratory variables was performed according to the tertiles of the SS. The correlation between SS and clinical, laboratory parameters was assessed by the Pearson correlation test. Multiple linear regression analysis was performed to identify the independent predictors of SS by including the parameters, which were correlated with SS in bivariate analysis. Standardized β-regression coefficients and their significance from multiple linear regression analysis were reported. A 2-tailed <italic>P</italic> <italic>&lt; </italic>.05 was considered significant.</p>
</sec>
</sec>
<sec id="section7-0003319712453305">
<title>Results</title>
<sec id="section8-0003319712453305">
<title>Baseline Characteristics</title>
<p>The mean SS was 15.1 ± 7. The SS classified as tertiles are SS<sub>low</sub> ≤11 (n = 259), SS<sub>mid</sub> &gt;11 and ≤18 (n = 283), and SS<sub>high</sub> &gt;18 (n = 298). Our data were collected from patients with 422 (50.2%) anterior STEMI, 351 (41.8%) inferior STEMI, 56 (6.7%) posterior and infero-right ventricle STEMI, and 11 (1.3%) high lateral STEMI (<xref ref-type="table" rid="table1-0003319712453305">Table 1</xref>).</p>
<table-wrap id="table1-0003319712453305" position="float">
<label>Table 1.</label>
<caption>
<p>Clinical Characteristics.</p>
</caption>
<graphic alternate-form-of="table1-0003319712453305" xlink:href="10.1177_0003319712453305-table1.tif"/>
<table>
<thead>
<tr>
<th>Syntax Score (SS)</th>
<th>SS<sub>low</sub> (≤11), n = 259, n (%)</th>
<th>SS<sub>mid</sub> (&gt;11 ≤ 18), n = 283, n (%)</th>
<th>SS<sub>high</sub> (&gt;18), n = 298, n (%)</th>
<th>
<italic>P</italic>
</th>
</tr>
</thead>
<tbody>
<tr>
<td colspan="5">Type of infarction</td>
</tr>
<tr>
<td> Anterior MI</td>
<td>64 (24.7)</td>
<td>149 (52.7)</td>
<td>209 (70.1)</td>
<td>&lt;.001</td>
</tr>
<tr>
<td> Inferior MI</td>
<td>153 (59.1)</td>
<td>119 (42)</td>
<td>79 (26.5)</td>
<td>&lt;.001</td>
</tr>
<tr>
<td> Post. and RV MI</td>
<td>34 (13.1)</td>
<td>14 (4.9)</td>
<td>8 (2.7)</td>
<td>.003</td>
</tr>
<tr>
<td> High lateral MI</td>
<td>8 (3)</td>
<td>1 (0.3)</td>
<td>2 (0.6)</td>
<td>.065</td>
</tr>
</tbody>
</table>
<table-wrap-foot>
<fn id="table-fn1-0003319712453305">
<p>Abbreviations: MI, myocardial infarction; Post. and RV; posterior and right ventricle.</p>
</fn>
</table-wrap-foot>
</table-wrap>
<p>Baseline demographic, echocardiographic, laboratory, and hemodynamic variables of patient groups were compared in <xref ref-type="table" rid="table2-0003319712453305">Table 2</xref>. Mean age of SS<sub>high</sub> group was higher than SS<sub>low</sub> and SS<sub>mid</sub> groups (<italic>P</italic> &lt; .05 for all). Frequency of HT, smoking, hyperlipidemia, and positive family history were similar between the groups (<italic>P</italic> &gt; .05 for all). Frequency of DM was different between patient groups (<italic>P</italic> &lt; .005 for all). Triglyceride, LDL, and HDL-cholesterol levels were similar between groups (<italic>P</italic> &gt; .05 for all). The WBC count of SS<sub>high</sub> group was higher compared with SS<sub>low</sub> and SS<sub>mid</sub> groups (<italic>P</italic> = .042 and <italic>P</italic> = .018, respectively). The N:L ratio of SS<sub>high</sub> group was higher compared with SS<sub>low</sub> and SS<sub>mid</sub> groups (<italic>P</italic> &lt; .001 for all). When SS was increased, both platelet (<italic>P</italic> = .136) and eosinophil counts (<italic>P</italic> = .112) were tended to decrease. Uric acid and creatinine levels of SS<sub>high</sub> group were higher than SS<sub>low</sub> group (<italic>P</italic> = .002 and <italic>P</italic> &lt; .001, respectively) and SS<sub>mid</sub> groups (<italic>P</italic> &lt; .001 and <italic>P</italic> = .003, respectively). Troponin and CK-MB levels of SS<sub>high</sub> group were higher than in SS<sub>low</sub> group (<italic>P</italic> = .001 and <italic>P</italic> = .001, respectively). The CK-MB activity of SS<sub>high</sub> group was higher than that of SS<sub>mid</sub> group (<italic>P</italic> = .018).</p>
<table-wrap id="table2-0003319712453305" position="float">
<label>Table 2.</label>
<caption>
<p>Comparison Baseline Characteristics.</p>
</caption>
<graphic alternate-form-of="table2-0003319712453305" xlink:href="10.1177_0003319712453305-table2.tif"/>
<table>
<thead>
<tr>
<th>Syntax Score (SS)</th>
<th>SS<sub>low</sub> (≤11), n = 259</th>
<th>SS<sub>mid</sub> (&gt;11 ≤ 18), n = 283</th>
<th>SS<sub>high</sub> (&gt;18), n = 298</th>
<th>
<italic>P</italic> (ANOVA)</th>
</tr>
</thead>
<tbody>
<tr>
<td>Age, years</td>
<td>55.2 ± 11.5<sup>a</sup>
</td>
<td>58.7 ± 12.8<sup>b</sup>
</td>
<td>61.4 ± 11.9</td>
<td>&lt;.001</td>
</tr>
<tr>
<td>Females, n (%)</td>
<td>46 (17.8)</td>
<td>88 (31.1)</td>
<td>84 (28.2)</td>
<td>.001<sup>c</sup>
</td>
</tr>
<tr>
<td>BMI, kg/m<sup>2</sup>
</td>
<td>26.3 ± 2.6</td>
<td>26.4 ± 2.5</td>
<td>26.4 ± 2.6</td>
<td>.888</td>
</tr>
<tr>
<td>SBP, mm Hg</td>
<td>121.3 ± 19.7</td>
<td>120.5 ± 20.5</td>
<td>116.8 ± 19.2<sup>d</sup>
</td>
<td>.018</td>
</tr>
<tr>
<td>DBP, mm Hg</td>
<td>73.8 ± 13.5</td>
<td>73.2 ± 14.1</td>
<td>71.4 ± 12.4</td>
<td>.091</td>
</tr>
<tr>
<td>Heart rate, beats/min</td>
<td>88.3 ± 13.8</td>
<td>89.6 ± 13.6</td>
<td>92.6 ± 15.4<sup>e</sup>
</td>
<td>.002</td>
</tr>
<tr>
<td>Ejection fraction, %</td>
<td>46.3 ± 10.4</td>
<td>46.6 ± 8.1</td>
<td>43.3 ± 9.3<sup>f</sup>
</td>
<td>&lt;.001</td>
</tr>
<tr>
<td>SS</td>
<td>7.3 ± 2.1</td>
<td>14.2 ± 2.1</td>
<td>22.7 ± 4.2</td>
<td>&lt;.001</td>
</tr>
<tr>
<td colspan="5">Medical history, n (%)</td>
</tr>
<tr>
<td> Hypertension</td>
<td>89 (34.4)</td>
<td>114 (40.3)</td>
<td>123 (41.3)</td>
<td>.204</td>
</tr>
<tr>
<td>  Diabetes mellitus</td>
<td>57 (22)</td>
<td>66 (23.3)</td>
<td>120 (40.3)</td>
<td>&lt;.001<sup>c</sup>
</td>
</tr>
<tr>
<td> Smoking</td>
<td>116 (44.8)</td>
<td>104 (36.7)</td>
<td>112 (37.6)</td>
<td>.112<sup>c</sup>
</td>
</tr>
<tr>
<td> Hyperlipidemia</td>
<td>78 (30.1)</td>
<td>71 (25.1)</td>
<td>69 (23.2)</td>
<td>.160<sup>c</sup>
</td>
</tr>
<tr>
<td> Family history</td>
<td>75 (29)</td>
<td>78 (27.6)</td>
<td>71 (23.8)</td>
<td>.360<sup>c</sup>
</td>
</tr>
<tr>
<td colspan="5">Laboratory findings</td>
</tr>
<tr>
<td> Hemoglobin, mg/dL</td>
<td>13.7 ± 1.9</td>
<td>13.3 ± 2.1</td>
<td>13.4 ± 1.9</td>
<td>.052</td>
</tr>
<tr>
<td> WBC, ×1000/µL</td>
<td>9.9 ± 3.7</td>
<td>9.8 ± 3.7</td>
<td>10.6 ± 4.4<sup>g</sup>
</td>
<td>.036</td>
</tr>
<tr>
<td>Neutrophil, ×1000/µL</td>
<td>6.8 ± 2.9</td>
<td>7.3 ± 3.3</td>
<td>8.2 ± 3.5<sup>h</sup>
</td>
<td>&lt;.001</td>
</tr>
<tr>
<td>Lymphocyte, ×1000/µL</td>
<td>2.1 ± 1<sup>i</sup>
</td>
<td>1.9 ± 0.8<sup>j</sup>
</td>
<td>1.6 ± 0.8</td>
<td>&lt;.001</td>
</tr>
<tr>
<td>N:L ratio</td>
<td>4 ± 2.9<sup>k</sup>
</td>
<td>4.8 ± 3.3<sup>l</sup>
</td>
<td>6.5 ± 3.9</td>
<td>&lt;.001</td>
</tr>
<tr>
<td>PLT count, ×10<sup>9</sup>/L</td>
<td>250 ± 74</td>
<td>243 ± 671</td>
<td>238 ± 79</td>
<td>.136</td>
</tr>
<tr>
<td>Eosinophil, ×1000/µL</td>
<td>0.27 ± 0.08</td>
<td>0.24 ± 0.1</td>
<td>0.22 ± 0.09</td>
<td>.112</td>
</tr>
<tr>
<td>Uric acid, mg/dL</td>
<td>5.6 ± 1.5</td>
<td>5.5 ± 1.4</td>
<td>6 ± 1.8<sup>m</sup>
</td>
<td>.001</td>
</tr>
<tr>
<td>Creatinine, mg/dL</td>
<td>0.9 ± 0.5</td>
<td>1 ± 0.5</td>
<td>1.1 ± 0.8<sup>n</sup>
</td>
<td>&lt;.001</td>
</tr>
<tr>
<td>LDL, mg/dL</td>
<td>125.1 ± 37.8</td>
<td>123.6 ± 36.8</td>
<td>119.7 ± 36.2</td>
<td>.218</td>
</tr>
<tr>
<td>HDL, mg/dL</td>
<td>37.9 ± 9</td>
<td>37.3 ± 8.6</td>
<td>38.5 ± 9.3</td>
<td>.654</td>
</tr>
<tr>
<td>Triglyceride, mg/dL</td>
<td>159.8 ± 154.8</td>
<td>145.7 ± 97.8</td>
<td>140.2 ± 81.2</td>
<td>.138</td>
</tr>
<tr>
<td>Fasting glucose, mg/dL</td>
<td>141.9 ± 87.1</td>
<td>145.5 ± 72</td>
<td>156.3 ± 84.7</td>
<td>.097</td>
</tr>
<tr>
<td>CK-MB, mg/mL</td>
<td>75.7 ± 94.3</td>
<td>85.5 ± 97.7</td>
<td>105.6 ± 110.4<sup>o</sup>
</td>
<td>.002</td>
</tr>
<tr>
<td>Troponin, mg/mL</td>
<td>11.8 ± 11.6<sup>p</sup>
</td>
<td>15.2 ± 16.4</td>
<td>16.1 ± 14.4</td>
<td>.002</td>
</tr>
<tr>
<td colspan="5">Prehospital medications, n (%)</td>
</tr>
<tr>
<td> β-Blocker use</td>
<td>22 (8.5)</td>
<td>27 (9.5)</td>
<td>26 (8.7)</td>
<td>.902<sup>c</sup>
</td>
</tr>
<tr>
<td> Statin use</td>
<td>78 (30.1)</td>
<td>71 (25.1)</td>
<td>69 (23.2)</td>
<td>.160<sup>c</sup>
</td>
</tr>
<tr>
<td> ACE inhibitor use</td>
<td>62 (23.9)</td>
<td>66 (23.3)</td>
<td>71 (23.8)</td>
<td>.984<sup>c</sup>
</td>
</tr>
<tr>
<td> ARB use</td>
<td>49 (18.9)</td>
<td align="center">55(19.4)</td>
<td>48 (16.1)</td>
<td>.534<sup>c</sup>
</td>
</tr>
<tr>
<td> Antidiabetic use</td>
<td>57 (22)</td>
<td>66 (23.3)</td>
<td>120 (40.3)</td>
<td>&lt;.001<sup>c</sup>
</td>
</tr>
<tr>
<td> Aspirin use</td>
<td>29 (11.2)</td>
<td>45 (15.9)</td>
<td>67 (22.5)</td>
<td>.02<sup>c</sup>
</td>
</tr>
</tbody>
</table>
<table-wrap-foot>
<fn id="table-fn2-0003319712453305">
<p>Abbreviations: ACE, angiotensin converting enzyme; ARB, angiotensin receptor blocker; BMI, body mass index; DBP, diastolic blood pressure; N:L ratio, neutrophil to lymphocyte ratio; SBP, systolic blood pressure; WBC, white blood cell count; PLT, platelets; LDL, low-density lipoprotein; HSL, high-density lipoprotein; CK-MB, creatine kinase MB.</p>
</fn>
<fn id="table-fn3-0003319712453305">
<p>
<sup>a</sup> <italic>P </italic>= .01 versus SS<sub>mid</sub> and <italic>P</italic> &lt; .001 versus SS<sub>high</sub>.</p>
</fn>
<fn id="table-fn4-0003319712453305">
<p>
<sup>b</sup> <italic>P</italic> = .007 versus SS<sub>high</sub>.</p>
</fn>
<fn id="table-fn5-0003319712453305">
<p>
<sup>c </sup>Chi-square test.</p>
</fn>
<fn id="table-fn6-0003319712453305">
<p>
<sup>d</sup> <italic>P </italic>= .009 versus SS<sub>low</sub> and <italic>P</italic> = .028 versus SS<sub>mid</sub>.</p>
</fn>
<fn id="table-fn7-0003319712453305">
<p>
<sup>e</sup> <italic>P</italic> = .001 versus SS<sub>low</sub> and <italic>P</italic> = .014 versus SS<sub>mid</sub>.</p>
</fn>
<fn id="table-fn8-0003319712453305">
<p>
<sup>f</sup> <italic>P</italic> &lt; .001 versus SS<sub>low</sub> and SS<sub>mid</sub>.</p>
</fn>
<fn id="table-fn9-0003319712453305">
<p>
<sup>g</sup> <italic>P </italic>= .042 versus SS<sub>low</sub> and <italic>P</italic> = .018 versus SS<sub>mid</sub>.</p>
</fn>
<fn id="table-fn10-0003319712453305">
<p>
<sup>h</sup> <italic>P</italic> &lt; .001 versus SS<sub>low</sub> and SS<sub>mid</sub>.</p>
</fn>
<fn id="table-fn11-0003319712453305">
<p>
<sup>i</sup> <italic>P</italic> = .001 versus SS<sub>mid</sub> and <italic>P</italic> &lt; .001 versus SS<sub>high</sub>.</p>
</fn>
<fn id="table-fn12-0003319712453305">
<p>
<sup>j</sup> <italic>P </italic>&lt; .001 versus SS<sub>high</sub>.</p>
</fn>
<fn id="table-fn13-0003319712453305">
<p>
<sup>k</sup> <italic>P</italic> = .007 versus SS<sub>mid</sub>, and <italic>P</italic> &lt; .001 versus SS<sub>high</sub>.</p>
</fn>
<fn id="table-fn14-0003319712453305">
<p>
<sup>l</sup> <italic>P</italic> &lt; .001 versus SS<sub>high</sub>.</p>
</fn>
<fn id="table-fn15-0003319712453305">
<p>
<sup>m</sup> <italic>P</italic> &lt; .001 versus SS<sub>low</sub> and <italic>P</italic> = .002 versus SS<sub>mid</sub>.</p>
</fn>
<fn id="table-fn16-0003319712453305">
<p>
<sup>n</sup> <italic>P</italic> = .003 versus SS<sub>mid</sub> and <italic>P</italic> &lt; .001 versus SS<sub>low</sub>.</p>
</fn>
<fn id="table-fn17-0003319712453305">
<p>
<sup>o</sup> <italic>P</italic> = .001 versus SS<sub>low</sub> and <italic>P</italic> = .018 versus SS<sub>mid</sub>.</p>
</fn>
<fn id="table-fn18-0003319712453305">
<p>
<sup>p</sup> <italic>P </italic>= .007 versus SS<sub>mid</sub> and <italic>P</italic> = .001 versus SS<sub>high</sub>.</p>
</fn>
</table-wrap-foot>
</table-wrap>
</sec>
<sec id="section9-0003319712453305">
<title>Predictors of SS</title>
<p>Bivariate and multivariate relationships of the SS values in groups were reported in <xref ref-type="table" rid="table3-0003319712453305">Table 3</xref>. SYNTAX score was correlated with age (<italic>P</italic> &lt; .001), presence of DM (<italic>P</italic> &lt; .001), EF (<italic>P</italic> &lt; .001), presence of dyslipidemia (<italic>P</italic> = .04), SBP (<italic>P</italic> = .020), DBP (<italic>P</italic> = .026), heart rate (<italic>P</italic> &lt; .001), LDL-cholesterol (<italic>P</italic> = .043), statin use (<italic>P</italic> = .04), antidiabetic use (<italic>P</italic> &lt; .001), UA (<italic>P</italic> &lt; .001), creatinine (<italic>P</italic> &lt; .001), CK-MB (<italic>P</italic> = .001), troponin (<italic>P</italic> = .005), WBC (<italic>P</italic> = .031), and N:L ratio (<italic>P</italic> &lt; .001) in bivariate analysis. Multivariate regression analysis showed that N:L ratio (β = .277, <italic>P</italic> &lt; .001), EF (β = −.086, <italic>P</italic> = .012), age (β = .104, <italic>P</italic> = .004), and presence of DM (β = .152, <italic>P</italic> &lt; .001) were the independent predictors for SS (usage of statins and antidiabetics were not included in multivariate analysis since the presence of hyperlipidemia and DM are included in the analysis). Relationship between N:L ratio and SS was demonstrated in <xref ref-type="fig" rid="fig1-0003319712453305">Figure 1</xref>.</p>
<fig id="fig1-0003319712453305" position="float">
<label>Figure 1</label>
<caption>
<p>Scatter graph showing strong correlation between SYNTAX score and neutrophil to lymphocyte ratio.</p>
</caption>
<graphic xlink:href="10.1177_0003319712453305-fig1.tif"/>
</fig>
<table-wrap id="table3-0003319712453305" position="float">
<label>Table 3.</label>
<caption>
<p>Bivariate and Multivariate Relationships of the SS in Patient Group (n = 840).</p>
</caption>
<graphic alternate-form-of="table3-0003319712453305" xlink:href="10.1177_0003319712453305-table3.tif"/>
<table>
<thead>
<tr>
<th>
</th>
<th>Pearson Correlation Coefficient</th>
<th>
<italic>P</italic>
</th>
<th>Standardized β Regression Coefficients<sup>a</sup>
</th>
<th>
<italic>P</italic>
</th>
</tr>
</thead>
<tbody>
<tr>
<td>Age</td>
<td>0.194</td>
<td>&lt;.001</td>
<td>0.104</td>
<td>.004</td>
</tr>
<tr>
<td>BMI</td>
<td>0.005</td>
<td>.882</td>
<td>
</td>
<td>
</td>
</tr>
<tr>
<td>EF, %</td>
<td>−0.135</td>
<td>&lt;.001</td>
<td>−0.086</td>
<td>.012</td>
</tr>
<tr>
<td>Gender, F/M</td>
<td>0.004</td>
<td>.908</td>
<td>
</td>
<td>
</td>
</tr>
<tr>
<td>Family history</td>
<td>0.042</td>
<td>.222</td>
<td>
</td>
<td>
</td>
</tr>
<tr>
<td>DM</td>
<td>0.178</td>
<td>&lt;.001</td>
<td>0.152</td>
<td>&lt;.001</td>
</tr>
<tr>
<td>Hyperlipidemia</td>
<td>−0.071</td>
<td>.040</td>
<td>−0.055</td>
<td>.274</td>
</tr>
<tr>
<td>HT</td>
<td>0.045</td>
<td>.189</td>
<td>
</td>
<td>
</td>
</tr>
<tr>
<td>Smoking</td>
<td>−0.051</td>
<td>.142</td>
<td>
</td>
<td>
</td>
</tr>
<tr>
<td>SBP, mm Hg</td>
<td>0.082</td>
<td>.020</td>
<td>0.035</td>
<td>.487</td>
</tr>
<tr>
<td>DBP, mm Hg</td>
<td>0.079</td>
<td>.026</td>
<td>−0.049</td>
<td>.314</td>
</tr>
<tr>
<td>Heart rate, beats/min</td>
<td>0.113</td>
<td>.001</td>
<td>0.045</td>
<td>.334</td>
</tr>
<tr>
<td>Triglyceride, mg/dL</td>
<td>0.066</td>
<td>.063</td>
<td>
</td>
<td>
</td>
</tr>
<tr>
<td>Total cholesterol, mg/dL</td>
<td>0.065</td>
<td>.069</td>
<td>
</td>
<td>
</td>
</tr>
<tr>
<td>LDL cholesterol, mg/dL</td>
<td>0.072</td>
<td>.043</td>
<td>
</td>
<td>
</td>
</tr>
<tr>
<td>HDL cholesterol, mg/dL</td>
<td>0.007</td>
<td>.834</td>
<td>
</td>
<td>
</td>
</tr>
<tr>
<td>Fasting glucose, mg/dL</td>
<td>0.055</td>
<td>.119</td>
<td>
</td>
<td>
</td>
</tr>
<tr>
<td>Uric acid, mg/dL</td>
<td>0.134</td>
<td>&lt;.001</td>
<td>0.063</td>
<td>.089</td>
</tr>
<tr>
<td>Creatinine, mg/dL</td>
<td>0.113</td>
<td>&lt;.001</td>
<td>0.008</td>
<td>.831</td>
</tr>
<tr>
<td>CK-MB, mg/mL</td>
<td>0.112</td>
<td>.001</td>
<td>0.011</td>
<td>.792</td>
</tr>
<tr>
<td>Troponin, mg/mL</td>
<td>0.91</td>
<td>.005</td>
<td>0.037</td>
<td>.353</td>
</tr>
<tr>
<td>Hemoglobin, mg/dL</td>
<td>−0.039</td>
<td>.260</td>
<td>
</td>
<td>
</td>
</tr>
<tr>
<td>WBC, x 1000/mL</td>
<td>0.074</td>
<td>.031</td>
<td>−0.010</td>
<td>.788</td>
</tr>
<tr>
<td>N:L ratio</td>
<td>0.330</td>
<td>&lt;.001</td>
<td>0.277</td>
<td>&lt;.001</td>
</tr>
<tr>
<td>Statin use</td>
<td>0.071</td>
<td>.040</td>
<td>
</td>
<td>
</td>
</tr>
<tr>
<td>Antidiabetic use</td>
<td>0.178</td>
<td>&lt;.001</td>
<td>
</td>
<td>
</td>
</tr>
<tr>
<td>Aspirin use</td>
<td>0.040</td>
<td>.250</td>
<td>
</td>
<td>
</td>
</tr>
<tr>
<td>ARB use</td>
<td>0.034</td>
<td>.318</td>
<td>
</td>
<td>
</td>
</tr>
<tr>
<td>ACEI use</td>
<td>0.019</td>
<td>.576</td>
<td>
</td>
<td>
</td>
</tr>
<tr>
<td>β-Blocker use</td>
<td>0.008</td>
<td>.826</td>
<td>
</td>
<td>
</td>
</tr>
</tbody>
</table>
<table-wrap-foot>
<fn id="table-fn19-0003319712453305">
<p>Abbreviations: ACE, angiotensin converting enzyme; ARB, angiotensin receptor blocker; BMI, body mass index; DBP, diastolic blood pressure; DM, diabetes mellitus; EF, ejection fraction; F, female; HT, hypertension; M, male; N:L ratio, neutrophil to lymphocyte ratio; SBP, systolic blood pressure; WBC, white blood cell count; LDL, low-density lipoprotein; HSL, high-density lipoprotein; CK-MB, creatine kinase MB.</p>
</fn>
<fn id="table-fn20-0003319712453305">
<p>
<sup>a</sup> From multiple linear regression.</p>
</fn>
</table-wrap-foot>
</table-wrap>
</sec>
</sec>
<sec id="section10-0003319712453305">
<title>Discussion</title>
<p>To the best of our knowledge, the present study is the first in the literature, which evaluates the relationship between the N:L ratio and SS in patients with STEMI. The main findings of this study are that (1) SS was independently correlated with N:L ratio in addition to DM, age, and EF and (2) the major increase in N:L ratio was observed in SS<sub>high</sub> group.</p>
<p>Atherogenesis is an active, inflammatory process<sup>
<xref ref-type="bibr" rid="bibr1-0003319712453305">1</xref>
</sup> with crucially acting functional/dysfunctional leukocytes.<sup>
<xref ref-type="bibr" rid="bibr18-0003319712453305">18</xref>
</sup> Neutrophils play role either in adaptive infarct healing or in leukocyte platelet aggregate formation and in reperfusion injury in the setting of acute coronary syndromes.<sup>
<xref ref-type="bibr" rid="bibr19-0003319712453305">19</xref>,<xref ref-type="bibr" rid="bibr20-0003319712453305">20</xref>
</sup>
</p>
<p>Several previous studies have evaluated the association of total and differential WBC count and presence and prognosis of CAD. White blood cell count, neutrophil count, and N: L ratio were reported as an independent prognostic predictor both in acute MI<sup>
<xref ref-type="bibr" rid="bibr21-0003319712453305">21</xref>
<xref ref-type="bibr" rid="bibr22-0003319712453305"/>
<xref ref-type="bibr" rid="bibr23-0003319712453305"/>–<xref ref-type="bibr" rid="bibr24-0003319712453305">24</xref>
</sup> and in stable CAD.<sup>
<xref ref-type="bibr" rid="bibr7-0003319712453305">7</xref>
</sup> To elucidate the pathophysiological mechanism of elevated neutrophils, neutrophil invasion was either shown in atherosclerotic plaques of an animal model<sup>
<xref ref-type="bibr" rid="bibr25-0003319712453305">25</xref>
</sup> or in the culprit clinical plaques of patients with acute coronary syndrome (ACS)<sup>
<xref ref-type="bibr" rid="bibr26-0003319712453305">26</xref>
</sup> besides the well-known neutrophilic infiltration of infarct zone that ultimately leads to fibrotic scar formation. Neutrophils not only promote fibrosis but also induce myocardial ischemia/infarction by assisting plaque disruption and by plugging of microvessels by coaggregating with platelets.<sup>
<xref ref-type="bibr" rid="bibr19-0003319712453305">19</xref>,<xref ref-type="bibr" rid="bibr27-0003319712453305">27</xref>
<xref ref-type="bibr" rid="bibr28-0003319712453305"/>
<xref ref-type="bibr" rid="bibr29-0003319712453305"/>–<xref ref-type="bibr" rid="bibr30-0003319712453305">30</xref>
</sup>
</p>
<p>Lymphocytes also play a crucial role in modulating the inflammatory response in atherosclerotic process<sup>
<xref ref-type="bibr" rid="bibr31-0003319712453305">31</xref>
</sup> and comparative lymphopenia in MI was postulated as a stress response mediated by increased endogenous cortisol,<sup>
<xref ref-type="bibr" rid="bibr32-0003319712453305">32</xref>,<xref ref-type="bibr" rid="bibr33-0003319712453305">33</xref>
</sup> whereas decreased CD4 lymphocyte subset was reported to be associated with increased cardiovascular events in renal transplant recipients.<sup>
<xref ref-type="bibr" rid="bibr31-0003319712453305">31</xref>
</sup>
</p>
<p>Our findings support previous studies on the association of differential WBC counts and the presence and prognosis of cardiovascular diseases.<sup>
<xref ref-type="bibr" rid="bibr34-0003319712453305">34</xref>
</sup> Increase in the severity of CAD with respect to SS was associated with increased neutrophils and decreased lymphocytes in our study and ultimately with increased N:L ratio. Similar to the current study, a relationship between N:L ratio and severity of CAD was reported in patients with stable CAD.<sup>
<xref ref-type="bibr" rid="bibr6-0003319712453305">6</xref>,<xref ref-type="bibr" rid="bibr7-0003319712453305">7</xref>
</sup> However, a similar independent relationship was not investigated in STEMI. Horne et al<sup>
<xref ref-type="bibr" rid="bibr6-0003319712453305">6</xref>
</sup> revealed high N or low L count as better independent predictor of death/MI in patients with or at high risk of CAD than total WBC count, whereas Papa et al<sup>
<xref ref-type="bibr" rid="bibr7-0003319712453305">7</xref>
</sup> reported that the N:L ratio was an independent predictor of cardiac death in angiographically proven patients with CAD. A stronger association between the N:L ratio and SS compared with the relationship between SS and WBC count in the present study in patients with acute STEMI supports recent literature revealing that the N:L ratio was a more important parameter than total WBC count with regard to the presence, severity, and extent of stable coronary atherosclerosis.<sup>
<xref ref-type="bibr" rid="bibr6-0003319712453305">6</xref>,<xref ref-type="bibr" rid="bibr7-0003319712453305">7</xref>
</sup> Further prospective studies assessing the predictive role of both SS and N:L ratio in conjunction for risk stratification might improve risk prediction in patients with STEMI.</p>
<p>Avramakis et al<sup>
<xref ref-type="bibr" rid="bibr35-0003319712453305">35</xref>
</sup> reported the changes in platelets and WBC subpopulations among patients with acute coronary syndrome (86 with AMI and 81 unstable angina pectoris) and controls (n = 83). They reported that patients with AMI had significantly lower platelet counts and eosinophil percentages compared with the controls. In our study, we studied only patients with STEMI and found that when SS was increased, both platelet and eosinophil counts tended to decrease. These changes may be markers of extent of myocardial damage. Differences in results may be attributed to factors such as patient characteristics and variations in treatment.</p>
<p>Previous studies have revealed serum UA as an independent predictor of mortality in patients with CAD<sup>
<xref ref-type="bibr" rid="bibr36-0003319712453305">36</xref>
</sup> and predictor of in-hospital mortality in patients with STEMI.<sup>
<xref ref-type="bibr" rid="bibr37-0003319712453305">37</xref>
</sup> Gur et al<sup>
<xref ref-type="bibr" rid="bibr38-0003319712453305">38</xref>
</sup> reported that serum UA was associated with the presence of CAD but not with the severity of CAD, in patients undergoing coronary angiography. A previous meta-analysis did not find any association between UA levels and cardiovascular events.<sup>
<xref ref-type="bibr" rid="bibr39-0003319712453305">39</xref>
</sup> Recently, Duran et al<sup>
<xref ref-type="bibr" rid="bibr40-0003319712453305">40</xref>
</sup> reported that UA was associated with the severity of CAD with no information on WBC count and its subtypes such as neutrophil and lymphocytes. The present study is consistent with pertinent literature revealing controversial results on the relationship between UA and CAD as UA was related to the severity of CAD in bivariate analysis but not in multiple linear regression analysis in 840 patients with STEMI in our study.</p>
<p>In conclusion, the N:L ratio was independently associated with the severity of CAD in patients with STEMI. However, UA was not independently associated with the severity of CAD in patients with STEMI.</p>
</sec>
</body>
<back>
<fn-group>
<fn fn-type="conflict" id="fn1-0003319712453305">
<label>Declaration of Conflicting Interests</label>
<p>The author(s) declared no potential conflicts of interest with respect to the research, authorship, and/or publication of this article.</p>
</fn>
<fn fn-type="financial-disclosure" id="fn2-0003319712453305">
<label>Funding</label>
<p>The author(s) received no financial support for the research, authorship, and/or publication of this article.</p>
</fn>
</fn-group>
<ref-list>
<title>References</title>
<ref id="bibr1-0003319712453305">
<label>1</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ross</surname>
<given-names>R</given-names>
</name>
</person-group>. <article-title>Atherosclerosis-an inflammatory disease</article-title>. <source>N Engl J Med</source>. <year>1999</year>;<volume>340</volume>(<issue>2</issue>):<fpage>115</fpage>–<lpage>126</lpage>.</citation>
</ref>
<ref id="bibr2-0003319712453305">
<label>2</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Libby</surname>
<given-names>P.</given-names>
</name>
</person-group> <article-title>What have we learned about the biology of atherosclerosis? The role of inflammation</article-title>. <source>Am J Cardiol</source>. <year>2001</year>;<volume>88</volume>(<issue>7B</issue>):<fpage>3J</fpage>–<lpage>6J</lpage>.</citation>
</ref>
<ref id="bibr3-0003319712453305">
<label>3</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Gurm</surname>
<given-names>HS</given-names>
</name>
<name>
<surname>Bhatt</surname>
<given-names>DL</given-names>
</name>
<name>
<surname>Lincoff</surname>
<given-names>AM</given-names>
</name>
<etal/>
</person-group>. <article-title>Impact of preprocedural white blood cell count on long term mortality after percutaneous coronary intervention: insights from the EPIC, EPILOG, and EPISTENT trials</article-title>. <source>Heart</source>. <year>2003</year>;<volume>89</volume>(<issue>10</issue>):<fpage>1200</fpage>–<lpage>1204</lpage>.</citation>
</ref>
<ref id="bibr4-0003319712453305">
<label>4</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Gurm</surname>
<given-names>HS</given-names>
</name>
<name>
<surname>Bhatt</surname>
<given-names>DL</given-names>
</name>
<name>
<surname>Gupta</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Ellis</surname>
<given-names>SG</given-names>
</name>
<name>
<surname>Topol</surname>
<given-names>EJ</given-names>
</name>
<name>
<surname>Lauer</surname>
<given-names>MS</given-names>
</name>
</person-group>. <article-title>Preprocedural white blood cell count and death after percutaneous coronary intervention</article-title>. <source>Am Heart J</source>. <year>2003</year>;<volume>146</volume>(<issue>4</issue>):<fpage>692</fpage>–<lpage>698</lpage>.</citation>
</ref>
<ref id="bibr5-0003319712453305">
<label>5</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Gillum</surname>
<given-names>RF</given-names>
</name>
<name>
<surname>Mussolino</surname>
<given-names>ME</given-names>
</name>
<name>
<surname>Madans</surname>
<given-names>JH</given-names>
</name>
</person-group>. <article-title>Counts of neutrophils, lymphocytes, and monocytes, cause-specific mortality and coronary heart disease: the NHANES-I epidemiologic follow-up study</article-title>. <source>Ann Epidemiol</source>. <year>2005</year>;<volume>15</volume>(<issue>4</issue>):<fpage>266</fpage>–<lpage>271</lpage>.</citation>
</ref>
<ref id="bibr6-0003319712453305">
<label>6</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Horne</surname>
<given-names>BD</given-names>
</name>
<name>
<surname>Anderson</surname>
<given-names>JL</given-names>
</name>
<name>
<surname>John</surname>
<given-names>JM</given-names>
</name>
<etal/>
</person-group>; <article-title>Intermountain Heart Collaborative Study Group. Which white blood cell subtypes predict increased cardiovascular risk?</article-title> <source>J Am Coll Cardiol</source>. <year>2005</year>;<volume>45</volume>(<issue>10</issue>):<fpage>1638</fpage>–<lpage>1643</lpage>.</citation>
</ref>
<ref id="bibr7-0003319712453305">
<label>7</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Papa</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Emdin</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Passino</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Michelassi</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Battaglia</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Cocci</surname>
<given-names>F</given-names>
</name>
</person-group>. <article-title>Predictive value of elevated neutrophil-lymphocyte ratio on cardiac mortality in patients with stable coronary artery disease</article-title>. <source>Clin Chim Acta</source>. <year>2008</year>;<volume>395</volume>(<issue>1-2</issue>):<fpage>27</fpage>–<lpage>31</lpage>.</citation>
</ref>
<ref id="bibr8-0003319712453305">
<label>8</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Núñez</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Núñez</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Bodí</surname>
<given-names>V</given-names>
</name>
<etal/>
</person-group>. <article-title>Usefulness of the neutrophil to lymphocyte ratio in predicting long-term mortality in ST segment elevation myocardial infarction</article-title>. <source>Am J Cardiol</source>. <year>2008</year>;<volume>101</volume>(<issue>6</issue>):<fpage>747</fpage>–<lpage>752</lpage>.</citation>
</ref>
<ref id="bibr9-0003319712453305">
<label>9</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Sianos</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Morel</surname>
<given-names>MA</given-names>
</name>
<name>
<surname>Kappetein</surname>
<given-names>AP</given-names>
</name>
<etal/>
</person-group>. <article-title>The SYNTAX Score: an angiographic tool grading the complexity of coronary artery disease</article-title>. <source>EuroIntervention</source>. <year>2005</year>;<volume>1</volume>(<issue>2</issue>):<fpage>219</fpage>–<lpage>227</lpage>.</citation>
</ref>
<ref id="bibr10-0003319712453305">
<label>10</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Capodanno</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Di Salvo</surname>
<given-names>ME</given-names>
</name>
<name>
<surname>Cincotta</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Miano</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Tamburino</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Tamburino</surname>
<given-names>C</given-names>
</name>
</person-group>. <article-title>Usefulness of the SYNTAX score for predicting clinical outcome after percutaneous coronary intervention of unprotected left main coronary artery disease</article-title>. <source>Circ Cardiovasc Interv</source>. <year>2009</year>;<volume>2</volume>(<issue>4</issue>):<fpage>302</fpage>–<lpage>308</lpage>.</citation>
</ref>
<ref id="bibr11-0003319712453305">
<label>11</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Capodanno</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Capranzano</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Di Salvo</surname>
<given-names>ME</given-names>
</name>
<etal/>
</person-group>. <article-title>Usefulness of SYNTAX score to select patients with left main coronary artery disease to be treated with coronary artery bypass graft</article-title>. <source>JACC Cardiovasc Interv</source>. <year>2009</year>;<volume>2</volume>(<issue>8</issue>):<fpage>731</fpage>–<lpage>738</lpage>.</citation>
</ref>
<ref id="bibr12-0003319712453305">
<label>12</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Valgimigli</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Serruys</surname>
<given-names>PW</given-names>
</name>
<name>
<surname>Tsuchida</surname>
<given-names>K</given-names>
</name>
<etal/>
</person-group>; <collab collab-type="author">ARTS II</collab>. <article-title>Cyphering the complexity of coronary artery disease using the syntax score to predict clinical outcome in patients with three-vessel lumen obstruction undergoing percutaneous coronary intervention</article-title>. <source>Am J Cardiol</source>. <year>2007</year>;<volume>99</volume>(<issue>8</issue>):<fpage>1072</fpage>–<lpage>1081</lpage>.</citation>
</ref>
<ref id="bibr13-0003319712453305">
<label>13</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wykrzykowska</surname>
<given-names>JJ</given-names>
</name>
<name>
<surname>Garg</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Girasis</surname>
<given-names>C</given-names>
</name>
<etal/>
</person-group>. <article-title>Value of the SYNTAX score (SX) for risk assessment in the “all-comers” population of the randomized multicenter LEADERS Trial</article-title>. <source>J Am Coll Cardiol</source>. <year>2010</year>;<volume>56</volume>(<issue>4</issue>):<fpage>272</fpage>–<lpage>277</lpage>.</citation>
</ref>
<ref id="bibr14-0003319712453305">
<label>14</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Girasis</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Garg</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Räber</surname>
<given-names>L</given-names>
</name>
<etal/>
</person-group>. <article-title>SYNTAX score and Clinical SYNTAX score as predictors of very long-term clinical outcomes in patients undergoing percutaneous coronary interventions: a substudy of SIRolimus-eluting stent compared with pacliTAXel-eluting stent for coronary revascularization (SIRTAX) trial</article-title>. <source>Eur Heart J</source>. <year>2011</year>;<volume>32</volume>(<issue>24</issue>):<fpage>3115</fpage>–<lpage>3127</lpage>.</citation>
</ref>
<ref id="bibr15-0003319712453305">
<label>15</label>
<citation citation-type="journal">. <article-title>Myocardial infarction redefined: a consensus document of The Joint European Society of Cardiology/American College of Cardiology Committee for the redefinition of myocardial infarction</article-title>. <source>Eur Heart J</source>. <year>2000</year>;<volume>21</volume>(<issue>18</issue>):<fpage>1502</fpage>–<lpage>1513</lpage>.</citation>
</ref>
<ref id="bibr16-0003319712453305">
<label>16</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Schiller</surname>
<given-names>NB</given-names>
</name>
<name>
<surname>Shah</surname>
<given-names>PM</given-names>
</name>
<name>
<surname>Crawford</surname>
<given-names>M</given-names>
</name>
<etal/>
</person-group>. <article-title>Recommendations for quantitation of the left ventricle by two-dimensional echocardiography. American Society of Echocardiography Committee on Standards, Subcommittee on Quantitation of Two-Dimensional Echocardiograms</article-title>. <source>J Am Soc Echocardiogr</source>. <year>1989</year>;<volume>2</volume>(<issue>5</issue>):<fpage>358</fpage>–<lpage>367</lpage>.</citation>
</ref>
<ref id="bibr17-0003319712453305">
<label>17</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Serruys</surname>
<given-names>PW</given-names>
</name>
<name>
<surname>Onuma</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Garg</surname>
<given-names>S</given-names>
</name>
<etal/>
</person-group>. <article-title>Assessment of the SYNTAX score in the Syntax study</article-title>. <source>EuroIntervention</source>. <year>2009</year>;<volume>5</volume>(<issue>1</issue>):<fpage>50</fpage>–<lpage>56</lpage>.</citation>
</ref>
<ref id="bibr18-0003319712453305">
<label>18</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hoffman</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Blum</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Baruch</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Kaplan</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Benjamin</surname>
<given-names>M</given-names>
</name>
</person-group>. <article-title>Leukocytes and coronary heart disease</article-title>. <source>Atherosclerosis</source>. <year>2004</year>;<volume>172</volume>(<issue>1</issue>):<fpage>1</fpage>–<lpage>6</lpage>.</citation>
</ref>
<ref id="bibr19-0003319712453305">
<label>19</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ott</surname>
<given-names>I</given-names>
</name>
<name>
<surname>Neumann</surname>
<given-names>FJ</given-names>
</name>
<name>
<surname>Gawaz</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Schmitt</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Schömig</surname>
<given-names>A</given-names>
</name>
</person-group>. <article-title>Increased neutrophil-platelet adhesion in patients with unstable angina</article-title>. <source>Circulation</source>. <year>1996</year>;<volume>94</volume>(<issue>6</issue>):<fpage>1239</fpage>–<lpage>1246</lpage>.</citation>
</ref>
<ref id="bibr20-0003319712453305">
<label>20</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Maxwell</surname>
<given-names>SRJ</given-names>
</name>
<name>
<surname>Lip</surname>
<given-names>GYH</given-names>
</name>
</person-group>. <article-title>Reperfusion injury: a review of the pathophysiology, clinical manifestations and therapeutic options</article-title>. <source>Int J Cardiol</source>. <year>1997</year>;<volume>58</volume>(<issue>2</issue>):<fpage>95</fpage>–<lpage>117</lpage>.</citation>
</ref>
<ref id="bibr21-0003319712453305">
<label>21</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Furman</surname>
<given-names>MI</given-names>
</name>
<name>
<surname>Becker</surname>
<given-names>RC</given-names>
</name>
<name>
<surname>Yarzebski</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Savegeau</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Gore</surname>
<given-names>JM</given-names>
</name>
<name>
<surname>Goldberg</surname>
<given-names>RJ</given-names>
</name>
</person-group>. <article-title>Effect of elevated leukocyte count on in-hospital mortality following acute myocardial infarction</article-title>. <source>Am J Cardiol</source>. <year>1996</year>;<volume>78</volume>(<issue>8</issue>):<fpage>945</fpage>–<lpage>948</lpage>.</citation>
</ref>
<ref id="bibr22-0003319712453305">
<label>22</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kirtane</surname>
<given-names>AJ</given-names>
</name>
<name>
<surname>Bui</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Murphy</surname>
<given-names>SA</given-names>
</name>
<name>
<surname>Barron</surname>
<given-names>HV</given-names>
</name>
<name>
<surname>Gibson</surname>
<given-names>CM</given-names>
</name>
</person-group>. <article-title>Association of peripheral neutrophilia with adverse angiographic outcomes in ST elevation myocardial infarction</article-title>. <source>Am J Cardiol</source>. <year>2004</year>;<volume>93</volume>(<issue>5</issue>):<fpage>532</fpage>–<lpage>536</lpage>.</citation>
</ref>
<ref id="bibr23-0003319712453305">
<label>23</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Avanzas</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Quiles</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Lopez de Sa</surname>
<given-names>E</given-names>
</name>
<etal/>
</person-group>. <article-title>Neutrophil count and infarct size in patients with acute myocardial infarction</article-title>. <source>Int J Cardiol</source>. <year>2004</year>;<volume>97</volume>(<issue>1</issue>):<fpage>155</fpage>–<lpage>156</lpage>.</citation>
</ref>
<ref id="bibr24-0003319712453305">
<label>24</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Fiarresga</surname>
<given-names>AJ</given-names>
</name>
<name>
<surname>Ferreira</surname>
<given-names>RC</given-names>
</name>
<name>
<surname>Feliciano</surname>
<given-names>J</given-names>
</name>
<etal/>
</person-group>. <article-title>Prognostic value of neutrophil response in the era of acute myocardial infarction mechanical reperfusion</article-title>. <source>Rev Port Cardiol</source>. <year>2004</year>;<volume>23</volume>(<issue>11</issue>):<fpage>1387</fpage>–<lpage>1396</lpage>.</citation>
</ref>
<ref id="bibr25-0003319712453305">
<label>25</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Eriksson</surname>
<given-names>EE</given-names>
</name>
<name>
<surname>Xie</surname>
<given-names>X</given-names>
</name>
<name>
<surname>Werr</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Thoren</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Lindbom</surname>
<given-names>L</given-names>
</name>
</person-group>. <article-title>Direct viewing of atherosclerosis in vivo: plaque invasion by leukocytes is initiated by the endothelial selectins</article-title>. <source>FASEB J</source>. <year>2001</year>;<volume>15</volume>(<issue>7</issue>):<fpage>1149</fpage>–<lpage>1157</lpage>.</citation>
</ref>
<ref id="bibr26-0003319712453305">
<label>26</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Naruko</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Ueda</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Haze</surname>
<given-names>K</given-names>
</name>
<etal/>
</person-group>. <article-title>Neutrophil infiltration of culprit lesions in acute coronary syndromes</article-title>. <source>Circulation</source>. <year>2002</year>;<volume>106</volume>(<issue>23</issue>):<fpage>2894</fpage>–<lpage>2900</lpage>.</citation>
</ref>
<ref id="bibr27-0003319712453305">
<label>27</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Sarma</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Laan</surname>
<given-names>CA</given-names>
</name>
<name>
<surname>Alam</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Jha</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Fox</surname>
<given-names>KA</given-names>
</name>
<name>
<surname>Dransfield</surname>
<given-names>I</given-names>
</name>
</person-group>. <article-title>Increased platelet binding to circulating monocytes in acute coronary syndromes</article-title>. <source>Circulation</source>. <year>2002</year>;<volume>105</volume>(<issue>18</issue>):<fpage>2166</fpage>–<lpage>2171</lpage>.</citation>
</ref>
<ref id="bibr28-0003319712453305">
<label>28</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Barron</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Cannon</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Murphy</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Braunwald</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Gibson</surname>
<given-names>CM</given-names>
</name>
</person-group>. <article-title>Association between white blood cell count, epicardial blood flow, myocardial perfusion, and clinical outcomes in the setting of acute myocardial infarction: a thrombolysis in myocardial infarction 10 substudy</article-title>. <source>Circulation</source>. <year>2000</year>;<volume>102</volume>(<issue>19</issue>):<fpage>2329</fpage>–<lpage>2334</lpage>.</citation>
</ref>
<ref id="bibr29-0003319712453305">
<label>29</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Pelizzon</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Dixon</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Stone</surname>
<given-names>G</given-names>
</name>
<etal/>
</person-group>. <article-title>Relation of admission white blood cell count to long-term outcomes after primary coronary angioplasty for acute myocardial infarction (The Stent PAMI Trial)</article-title>. <source>Am J Cardiol</source>. <year>2003</year>;<volume>91</volume>(<issue>6</issue>):<fpage>729</fpage>–<lpage>731</lpage>.</citation>
</ref>
<ref id="bibr30-0003319712453305">
<label>30</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Siminiak</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Flores</surname>
<given-names>N</given-names>
</name>
<name>
<surname>Sheridan</surname>
<given-names>D</given-names>
</name>
</person-group>. <article-title>Neutrophil interactions with endothelium and platelets: possible role in the development of cardiovascular injury</article-title>. <source>Eur Heart J</source>. <year>1995</year>;<volume>16</volume>(<issue>2</issue>):<fpage>160</fpage>–<lpage>170</lpage>.</citation>
</ref>
<ref id="bibr31-0003319712453305">
<label>31</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ducloux</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Challier</surname>
<given-names>B</given-names>
</name>
<name>
<surname>Saas</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Tiberghien</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Chalopin</surname>
<given-names>JM</given-names>
</name>
</person-group>. <article-title>CD4 cell lymphopenia and atherosclerosis in renal transplant recipients</article-title>. <source>J Am Soc Nephrol</source>. <year>2003</year>;<volume>14</volume>(<issue>3</issue>):<fpage>767</fpage>–<lpage>772</lpage>.</citation>
</ref>
<ref id="bibr32-0003319712453305">
<label>32</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Onsrud</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Thorsby</surname>
<given-names>E.</given-names>
</name>
</person-group> <article-title>Influence of in vivo hydrocortisone on some human blood lymphocyte subpopulations. I. Effect on natural killer cell activity</article-title>. <source>Scand J Immunol</source>. <year>1981</year>;<volume>13</volume>(<issue>6</issue>):<fpage>573</fpage>–<lpage>579</lpage>.</citation>
</ref>
<ref id="bibr33-0003319712453305">
<label>33</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Thomson</surname>
<given-names>SP</given-names>
</name>
<name>
<surname>Gibbons</surname>
<given-names>RJ</given-names>
</name>
<name>
<surname>Smars</surname>
<given-names>PA</given-names>
</name>
<etal/>
</person-group>. <article-title>Incremental value of the leukocyte differential and the rapid creatine kinase-MB isoenzyme for the early diagnosis of myocardial infarction</article-title>. <source>Ann Intern Med</source>. <year>1995</year>;<volume>122</volume>(<issue>5</issue>):<fpage>335</fpage>–<lpage>341</lpage>.</citation>
</ref>
<ref id="bibr34-0003319712453305">
<label>34</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Sabatine</surname>
<given-names>MS</given-names>
</name>
<name>
<surname>Morrow</surname>
<given-names>DA</given-names>
</name>
<name>
<surname>Cannon</surname>
<given-names>CP</given-names>
</name>
<etal/>
</person-group>. <article-title>Relationship between baseline white blood cell count and degree of coronary artery disease and mortality in patients with acute coronary syndromes. A TACTICS-TIMI 18 Substudy</article-title>. <source>J Am Coll Cardiol</source>. <year>2002</year>;<volume>40</volume>(<issue>10</issue>):<fpage>1761</fpage>–<lpage>1768</lpage>.</citation>
</ref>
<ref id="bibr35-0003319712453305">
<label>35</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Avramakis</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Papadimitraki</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Papakonstandinou</surname>
<given-names>D</given-names>
</name>
<etal/>
</person-group>. <article-title>Platelets and white blood cell subpopulations among patients with myocardial infarction and unstable angina</article-title>. <source>Platelets</source>. <year>2007</year>;<volume>18</volume>(<issue>1</issue>):<fpage>16</fpage>–<lpage>23</lpage>.</citation>
</ref>
<ref id="bibr36-0003319712453305">
<label>36</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Bickel</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Rupprecht</surname>
<given-names>HJ</given-names>
</name>
<name>
<surname>Blankenberg</surname>
<given-names>S</given-names>
</name>
<etal/>
</person-group>. <article-title>Serum uric acid as an independent predictor of mortality in patients with angiographically proven coronary artery disease</article-title>. <source>Am J Cardiol</source>. <year>2002</year>;<volume>89</volume>(<issue>1</issue>):<fpage>12</fpage>–<lpage>17</lpage>.</citation>
</ref>
<ref id="bibr37-0003319712453305">
<label>37</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lazzeri</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Valente</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Chiostri</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Sori</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Bernardo</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Gensini</surname>
<given-names>GF</given-names>
</name>
</person-group>. <article-title>Gensini uric acid in the acute phase of ST elevation myocardial infarction submitted to primary PCI: its prognostic role and relation with inflammatory markers: a single center experience</article-title>. <source>Int J Cardiol</source>. <year>2010</year>;<volume>138</volume>(<issue>2</issue>):<fpage>206</fpage>–<lpage>209</lpage>.</citation>
</ref>
<ref id="bibr38-0003319712453305">
<label>38</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Gur</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Yilmaz</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Demirbag</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Aksoy</surname>
<given-names>N</given-names>
</name>
</person-group>. <article-title>Relation of serum uric acid levels with the presence and severity of angiographic coronary artery disease</article-title>. <source>Angiology</source>. <year>2008</year>;<volume>59</volume>(<issue>2</issue>):<fpage>166</fpage>–<lpage>171</lpage>.</citation>
</ref>
<ref id="bibr39-0003319712453305">
<label>39</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wheeler</surname>
<given-names>JG</given-names>
</name>
<name>
<surname>Juzwishin</surname>
<given-names>KD</given-names>
</name>
<name>
<surname>Eiriksdottir</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Gudnason</surname>
<given-names>V</given-names>
</name>
<name>
<surname>Danesh</surname>
<given-names>J</given-names>
</name>
</person-group>. <article-title>Serum uric acid and coronary heart disease in 9,458 incident cases and 155,084 controls: prospective study and meta-analysis</article-title>. <source>PLoS Med</source>. <year>2005</year>;<volume>2</volume>(<issue>3</issue>):<fpage>e76</fpage>.</citation>
</ref>
<ref id="bibr40-0003319712453305">
<label>40</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Duran</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Kalay</surname>
<given-names>N</given-names>
</name>
<name>
<surname>Akpek</surname>
<given-names>M</given-names>
</name>
<etal/>
</person-group>. <article-title>High levels of serum uric acid predict severity of coronary artery disease in patients with acute coronary syndrome [published online November 21]</article-title>. <source>Angiology</source>. <year>2011</year>. <comment>doi: 10.1177/0003319711426868</comment>.</citation>
</ref>
</ref-list>
</back>
</article>